Indo-Bio Active Labs Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 15-11-2024
- Paid Up Capital ₹ 1.15 M
as on 15-11-2024
- Company Age 25 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 27.51 Cr
as on 15-11-2024
- Revenue -4.89%
(FY 2023)
- Profit -23.93%
(FY 2023)
- Ebitda -8.25%
(FY 2023)
- Net Worth 27.93%
(FY 2023)
- Total Assets -63.27%
(FY 2023)
About Indo-Bio Active Labs
The Corporate was formerly known as Indo-Bio Active Lab Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.15 M.
The company has closed loans amounting to ₹27.51 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dinesh Bothra, Utkarsh Munot, and Pragati Bothara serve as directors at the Company.
- CIN/LLPIN
U24233PN1999PTC013331
- Company No.
013331
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Indo-Bio Active Labs Private Limited offer?
Indo-Bio Active Labs Private Limited offers a wide range of products and services, including Anticoagulant and Antiplatelet Drugs, Enoxaparin Injection.
Who are the key members and board of directors at Indo-Bio Active Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Bothra  | Director | 15-Feb-1999 | Current |
| Utkarsh Munot | Director | 31-Dec-2018 | Current |
| Pragati Bothara | Director | 29-Sep-2000 | Current |
Financial Performance and Corporate Structure Insights of Indo-Bio Active Labs.
Indo-Bio Active Labs Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.89% decrease. The company also saw a substantial fall in profitability, with a 23.93% decrease in profit. The company's net worth Soared by an impressive increase of 27.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indo-Bio Active Labs?
In 2023, Indo-Bio Active Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Z F Steering Gear (India) LimitedActive 43 years 10 monthsDinesh Bothra and Utkarsh Munot are mutual person
Accela Pharmaceuticals Private LimitedActive 14 years 5 monthsDinesh Bothra and Pragati Bothara are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Dec 2021 | ₹26.00 Cr | Satisfied |
Others Creation Date: 14 May 2019 | ₹8.80 M | Satisfied |
Technology Information; Forecasting & Assesment Council Creation Date: 26 Mar 2004 | ₹3.50 M | Satisfied |
How Many Employees Work at Indo-Bio Active Labs?
Unlock and access historical data on people associated with Indo-Bio Active Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indo-Bio Active Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indo-Bio Active Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
